Deep brain stimulation in treatment-resistant depression in mice: Comparison with the CRF1 antagonist, SSR125543

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 213-220

  Dournes, Carine ^a   Beeské, Sandra ^a   Belzung, Catherine ^b   Griebel, Guy ^a  

^a SANOFI   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Cingulate cortex; CRF1 antagonist; Deep brain stimulation; Fluoxetine; Mice; Treatment resistant depression

Indexed keywords

4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FLUOXETINE; SODIUM CHLORIDE;

AGGRESSIVENESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; CHRONIC STRESS; CINGULATE GYRUS; CONTROLLED STUDY; DEPRESSION; HYPERACTIVITY; INTERMETHOD COMPARISON; MALE; MOTIVATION; MOUSE; NONHUMAN; RECEPTOR BLOCKING; TREATMENT DURATION; UNPREDICTABLE CHRONIC MILD STRESS; VALIDATION PROCESS;

AGGRESSION; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; DEEP BRAIN STIMULATION; DEPRESSION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FLUOXETINE; HYDROCARBONS, HALOGENATED; MALE; MICE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; THIAZINES;

EID: 84868247567     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.07.019     Document Type: Article

References (56)

1. 1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatr 2004, 9:278-286.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. 10.1016/j.neubiorev.2012.06.001.
3. Anderson R.J., Frye M.A., Abulseoud O.A., Lee K.H., McGillivray J., Berk M., et al. Deep brain stimulation for treatment-resistant depression: Efficacy, safety and mechanisms of action. Neurosci Biobehav Rev 2012.
4. Andrews R.J. Neuromodulation: advances in the next five years. Ann N Y Acad Sci 2010, 1199:204-211.
5. Benabid A.L., Wallace B., Mitrofanis J., Xia R., Piallat B., Chabardes S., et al. A putative generalized model of the effects and mechanism of action of high frequency electrical stimulation of the central nervous system. Acta Neurol Belg 2005, 105:149-157.
6. Bernstein J.G., Boyden E.S. Optogenetic tools for analyzing the neural circuits of behavior. Trends Cogn Sci 2011, 15:592-600.
7. Covington H.E., Lobo M.K., Maze I., Vialou V., Hyman J.M., Zaman S., et al. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 2010, 30:16082-16090.
8. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
9. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
10. Deacon R.M. Assessing nest building in mice. Nat Protoc 2006, 1:1117-1119.
11. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002, 12:527-544.
12. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
13. Encinas J.M., Hamani C., Lozano A.M., Enikolopov G. Neurogenic hippocampal targets of deep brain stimulation. J Comp Neurol 2011, 519:6-20.
14. Falowski S.M., Sharan A., Reyes B.A., Sikkema C., Szot P., Van Bockstaele E.J. An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 2011, 69:1281-1290.
15. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego.
16. Friedman A., Lax E., Dikshtein Y., Abraham L., Flaumenhaft Y., Sudai E., et al. Electrical stimulation of the lateral habenula produces enduring inhibitory effect on cocaine seeking behavior. Neuropharmacology 2010, 59:452-459.
17. Friedman A., Lax E., Dikshtein Y., Abraham L., Flaumenhaft Y., Sudai E., et al. Electrical stimulation of the lateral habenula produces an inhibitory effect on sucrose self-administration. Neuropharmacology 2011, 60:381-387.
18. Griebel G., Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nat Rev Drug Discov 2012, 11:462-478.
19. 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 2002, 99:6370-6375.
20. 1 receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 2002, 301:333-345.
21. Guillot P.V., Roubertoux P.L., Crusio W.E. Hippocampal mossy fiber distributions and intermale aggression in seven inbred mouse strains. Brain Res 1994, 660:167-169.
22. Gully D., Geslin M., Serva L., Fontaine E., Roger P., Lair C., et al. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-me thylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): A potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization. J Pharmacol Exp Ther 2002, 301:322-332.
23. Hamani C., Diwan M., Isabella S., Lozano A.M., Nobrega J.N. Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J Psychiatr Res 2010, 44:683-687.
24. Hamani C., Diwan M., Macedo C.E., Brandao M.L., Shumake J., Gonzalez-Lima F., et al. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 2010, 67:117-124.
25. Hamani C., Machado D.C., Hipolide D.C., Dubiela F.P., Suchecki D., Macedo C.E., et al. Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor. Biol Psychiatry 2012, 71:30-35.
26. Hamani C., Nobrega J.N. Deep brain stimulation in clinical trials and animal models of depression. Eur J Neurosci 2010, 32:1109-1117.
27. Isingrini E., Camus V., Le Guisquet A.M., Pingaud M., Devers S., Belzung C. Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS One 2010, 5:e10404.
28. Jayatissa M.N., Bisgaard C., Tingstrom A., Papp M., Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31:2395-2404.
29. Kennedy S.H., Giacobbe P., Rizvi S.J., Placenza F.M., Nishikawa Y., Mayberg H.S., et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011, 168:502-510.
30. Louis C., Cohen C., Depoortere R., Griebel G. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat. Neuropsychopharmacology 2006, 31:2180-2187.
31. Lozano A.M., Giacobbe P., Hamani C., Rizvi S.J., Kennedy S.H., Kolivakis T.T., et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2012, 116:315-322.
32. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999, 156:675-682.
33. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
34. Meng H., Wang Y., Huang M., Lin W., Wang S., Zhang B. Chronic deep brain stimulation of the lateral habenula nucleus in a rat model of depression. Brain Res 2011, 1422:32-38.
35. Mineur Y.S., Prasol D.J., Belzung C., Crusio W.E. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet 2003, 33:513-519.
36. Misslin R., Belzung C., Vogel E. Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behav Process 1989, 8:119-132.
37. Nierenberg A.A., Amsterdam J.D. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990, 51(Suppl.):39-47.
38. Overstreet D.H., Griebel G. Antidepressant-like effects of CRF(1) receptor antagonist SSR125543 in an animal model of depression. Eur J Pharmacol 2004, 497:49-53.
39. Pfister J.P., Tass P.A. STDP in oscillatory recurrent networks: theoretical conditions for desynchronization and applications to deep brain stimulation. Front Comput Neurosci 2010, 4.
40. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2009, 35:192-216.
41. Richardson-Jones J.W., Craige C.P., Nguyen T.H., Kung H.F., Gardier A.M., Dranovsky A., et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 2011, 31:6008-6018.
42. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905-1917.
43. Samuels B.A., Leonardo E.D., Gadient R., Williams A., Zhou J., David D.J., et al. Modeling treatment-resistant depression. Neuropharmacology 2011, 61:408-413.
44. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
45. Shah R.S., Chang S.Y., Min H.K., Cho Z.H., Blaha C.D., Lee K.H. Deep brain stimulation: technology at the cutting edge. J Clin Neurol 2010, 6:167-182.
46. Surget A., Belzung C. Unpredictable chronic mild stress in mice. Experimental Models in Neurobehavioral Research 2008, 79-112. Nova Science, New York. A.V. Kalueff, J.L. Laporte (Eds.).
47. Surget A., Belzung C. Unpredictable chronic mild stress in mice. Experimental Models in Neurobehavioral Research 2008, 79-112. Nova Science, New York. A.V. Kalueff, J.L. Laporte (Eds.).
48. Surget A., Belzung C. Unpredictable chronic mild stress in mice. Experimental Models in Neurobehavioral Research 2008, 79-112. Nova Science, New York. A.V. Kalueff, J.L. Laporte (Eds.).
49. Surget A., Belzung C. Unpredictable chronic mild stress in mice. Experimental Models in Neurobehavioral Research 2008, 79-112. Nova Science, New York. A.V. Kalueff, J.L. Laporte (Eds.).
50. Surget A., Belzung C. Unpredictable chronic mild stress in mice. Experimental Models in Neurobehavioral Research 2009, 79-112. Nova Science, New York. A.V. Kalueff, J.L. Laporte (Eds.).
51. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008, 64:293-301.
52. Surget A., Tanti A., Leonardo E.D., Laugeray A., Rainer Q., Touma C., et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011, 16:1177-1188.
53. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2008, 34:1363-1380.
54. Toda H., Hamani C., Fawcett A.P., Hutchison W.D., Lozano A.M. The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J Neurosurg 2008, 108:132-138.
55. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997, 134:319-329.
56. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34.